Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Yoshiaki Kamei"'
Autor:
Kana Taguchi, PhD, Yoshiaki Kamei, PhD, Erina Kusakabe, MD, Michiko Yamashita, PhD, Haruna Noda, MD, Reina Aoki, MD, Kanako Nishiyama, MD, Akari Murakami, PhD, Hiroaki Tanaka, PhD, Megumi Matsuda, PhD, Teruhito Kido, PhD, Norio Sato, PhD, Yasutsugu Takada, PhD
Publikováno v:
Radiology Case Reports, Vol 17, Iss 5, Pp 1737-1740 (2022)
A non-traumatic abdominal wall hematoma is rare, and occurs occasionally due to coughing, physical activity, or antithrombotic/anticoagulant therapy. The condition is usually unilateral; however, rare bilateral cases have been reported. Here, we repo
Externí odkaz:
https://doaj.org/article/48012c60f97f4e3ba2ddd32a31c341c0
Autor:
Haruna Noda, Michiko Yamashita, Akari Murakami, Kumiko Okujima, Kana Takemoto, Megumi Takaoka, Erina Kusakabe, Reina Aoki, Kana Taguchi, Kanako Nishiyama, Riko Kitazawa, Yoshiaki Kamei, Yasutsugu Takada
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1175-1181 (2021)
A 34-year-old woman with a rapidly growing right breast mass visited our hospital. The mass was diagnosed as a right breast cancer (cT3N1M0 stage ⦀A). Her serum leucocyte count and C-reactive protein levels were high, and she had persistent fever.
Externí odkaz:
https://doaj.org/article/adaf1817fe2341b88715f7da32f87003
Autor:
Michiko Yamashita, Yoshiaki Kamei, Akari Murakami, Erina Ozaki, Kumiko Okujima, Kana Takemoto, Megumi Takaoka, Daiki Tsukamoto, Erina Kusakabe, Tomoyuki Shidahara, Haruna Noda, Reina Aoki, Kana Taguchi, Kanako Nishiyama, Mariko Eguchi, Yasutsugu Takada
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)
Abstract Background Metaplastic carcinoma of the breast consists of both invasive ductal carcinoma and metaplastic carcinoma. This rare subtype of cancer has a poor prognosis. The development of metaplastic breast cancer and relationship with BRCA1 a
Externí odkaz:
https://doaj.org/article/8805da2c65e44a08b0bbc29a48c0e055
Autor:
Kana Kobayashi-Taguchi, Takashi Saitou, Yoshiaki Kamei, Akari Murakami, Kanako Nishiyama, Reina Aoki, Erina Kusakabe, Haruna Noda, Michiko Yamashita, Riko Kitazawa, Takeshi Imamura, Yasutsugu Takada
Publikováno v:
Molecules, Vol 27, Iss 10, p 3340 (2022)
Fibroadenomas (FAs) and phyllodes tumors (PTs) are major benign breast tumors, pathologically classified as fibroepithelial tumors. Although the clinical management of PTs differs from FAs, distinction by core needle biopsy diagnoses is still challen
Externí odkaz:
https://doaj.org/article/5c516d29c5ea4df8990f41ee1ac5e44b
Autor:
Kana Kobayashi, Hajime Yano, Akihiro Umakoshi, Shirabe Matsumoto, Ayano Mise, Yu Funahashi, Yoshitomo Ueno, Yoshiaki Kamei, Yasutsugu Takada, Yoshiaki Kumon, Takanori Ohnishi, Junya Tanaka
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 18, Iss 4, Pp 229-241 (2016)
CD200 induces immunosuppression in myeloid cells expressing its receptor CD200R, which may have consequences for tumor immunity. We found that human carcinoma tissues express not only full-length CD200 (CD200L) but also its truncated form, CD200S. Al
Externí odkaz:
https://doaj.org/article/2fb2b57060e14c03bd6ec087d39e44c7
Publikováno v:
Dose-Response, Vol 15 (2017)
To investigate the influence of low-dose-rate irradiation on the growth of silkworms, Bombyx mori , eggs of silkworms were randomly divided into 2 groups and were grown on either low-dose-radiation-emitting sheets or control sheets. On the radiation-
Externí odkaz:
https://doaj.org/article/c1337b4bd2e244f5bd58f4c160fd370a
Autor:
Haruna Noda, Junpei Suzuki, Yuko Matsuoka, Akira Matsumoto, Makoto Kuwahara, Yoshiaki Kamei, Yasutsugu Takada, Masakatsu Yamashita
Publikováno v:
Cancer Science.
Autor:
Kanako Nishiyama, Masashi Maekawa, Akari Murakami, Kaho Utsunomiya, Kana Takemoto, Erina Kusakabe, Haruna Noda, Reina Aoki, Kana Taguchi, Michiko Yamashita, Tomoya Nakagita, Jun Nakayama, Mami Chosei, Takeshi Kiyoi, Yoshiaki Kamei, Hiroyuki Takeda, Yasutsugu Takada, Shigeki Higashiyama
Publikováno v:
Cancer Research. 82:P5-10
Overexpression of human epidermal growth factor receptor 2 (HER2) in breast cancer is correlated with poor prognosis. HER2-targeting drugs have been successful to treat HER2-positive breast cancer. However, the acquisition of the drug resistance with
Autor:
Yuri Kimura, Norio Masumoto, Sadako Akashi-Tanaka, Kayo Fukui, Midori Noma, Aya Nagata, Takashi Nakamura, Hiroaki Shima, Toshitaka Okuno, Akari Murakami, Yoshiaki Kamei, Shogo Nakano, Koji Arihiro
Publikováno v:
Cancer Research. 83:P3-04
Background: Tumor-infiltrating lymphocytes (TILs) are a useful prognostic factor and predictive biomarker of neoadjuvant chemotherapy treatment response for breast cancer, especially in human epidermal growth factor receptor type 2 (HER2)-positive br
Autor:
Daiki Tsukamoto, Mariko Eguchi, Akari Murakami, Erina Ozaki, Kana Taguchi, Kanako Nishiyama, Tomoyuki Shidahara, Michiko Yamashita, Yasutsugu Takada, Haruna Noda, Kumiko Okujima, Erina Kusakabe, Kana Takemoto, Megumi Takaoka, Yoshiaki Kamei, Reina Aoki
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background Metaplastic carcinoma of the breast consists of both invasive ductal carcinoma and metaplastic carcinoma. This rare subtype of cancer has a poor prognosis. The development of metaplastic breast cancer and relationship with BRCA1 are not we